DR FURST MEDISINSK LABORATORIUM AS

1051 OSLO

Finances

Return on Equity

91,28 %

Current Ratio

0,99

Debt-to-Equity Ratio

3,81

Key figures (NOK)	2022	2021	2020	2019
Revenue	1 002 831 000	1 010 347 000	864 142 000	815 523 000
Net Income	65 615 000	108 684 000	109 326 000	104 914 000
Total Assets	551 132 000	659 433 000	269 253 000	232 486 000
Total Equity	71 887 000	118 083 000	143 632 000	138 367 000

Income (NOK)	2022	2021	2020	2019
Revenue	1 002 831 000	1 010 347 000	864 142 000	815 523 000
Expenditure	905 145 000	864 615 000	790 255 000	738 874 000
Operating Profit	97 686 000	145 733 000	73 886 000	76 650 000
Financial Income	1 784 000	669 000	52 992 000	45 379 000
Financial Costs	8 910 000	3 924 000	561 000	182 000
Financial Balance	−7 126 000	−3 255 000	52 431 000	45 197 000
Earnings Before Tax	90 560 000	142 477 000	126 317 000	121 847 000
Tax	24 945 000	33 793 000	16 990 000	16 933 000
Net Income	65 615 000	108 684 000	109 326 000	104 914 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	348 209 000	358 775 000	48 554 000	89 182 000
Total Current Assets	202 923 000	300 658 000	220 699 000	143 304 000
Total Assets	551 132 000	659 433 000	269 253 000	232 486 000
Total Retained Equity	31 346 000	71 829 000	97 377 000	92 113 000
Total Equity	71 887 000	118 083 000	143 632 000	138 367 000
Total Long-Term Debt	274 073 000	315 794 000	2 469 000	1 330 000
Total Current Debt	205 173 000	225 556 000	123 153 000	92 789 000
Total Equity and Debt	551 132 000	659 433 000	269 253 000	232 486 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	1 002 831 000	958 112 000	864 142 000	815 523 000
Other Income	0	52 235 000	0	0
Revenue	1 002 831 000	1 010 347 000	864 142 000	815 523 000
Cost of Goods Sold	0	0	0	0
Salary Costs	414 646 000	387 939 000	45 764 000	41 862 000
Depreciation	58 898 000	35 073 000	0	167 000
Impairment	0	0	0	0
Expenditure	905 145 000	864 615 000	790 255 000	738 874 000
Operating Profit	97 686 000	145 733 000	73 886 000	76 650 000
Financial Income	1 784 000	669 000	52 992 000	45 379 000
Financial Costs	8 910 000	3 924 000	561 000	182 000
Financial Balance	−7 126 000	−3 255 000	52 431 000	45 197 000
Dividends	0	0	0	0
Net Income	65 615 000	108 684 000	109 326 000	104 914 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	243 498 000	276 844 000	0	0
Total Intangible Assets	245 457 000	281 294 000	2 474 000	2 726 000
Real Eastate	5 077 000	5 999 000	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	75 002 000	70 126 000	1 168 000	0
Total Tangible Assets	80 079 000	76 125 000	1 168 000	0
Total Fiancial Fixed Assets	22 674 000	1 356 000	44 912 000	86 456 000
Total Fixed Assets	348 209 000	358 775 000	48 554 000	89 182 000
Stock	40 547 000	46 188 000	0	0
Total Investments	0	0	0	0
Cash, Bank	24 548 000	25 158 000	3 318 000	41 318 000
Total Current Assets	202 923 000	300 658 000	220 699 000	143 304 000
Total Assets	551 132 000	659 433 000	269 253 000	232 486 000
Total Equity	71 887 000	118 083 000	143 632 000	138 367 000
Short-Term Group Debt	65 911 000	51 612 000	98 749 000	69 946 000
Total Long-Term Debt	274 073 000	315 794 000	2 469 000	1 330 000
Creditors	43 135 000	60 284 000	5 872 000	667 000
Unpaid Taxes	32 677 000	34 575 000	5 281 000	5 288 000
Dividends	0	0	0	0
Other Current Debt	51 334 000	59 168 000	4 848 000	4 803 000
Total Current Debt	205 173 000	225 556 000	123 153 000	92 789 000
Total Equity and Debt	551 132 000	659 433 000	269 253 000	232 486 000

Financial indicators	2022	2021	2020	2019
Return on Equity	91,28 %	92,04 %	76,12 %	75,82 %
Debt-to-Equity Ratio	3,81	2,67	0,02	0,01
Operating Profit Margin	9,74 %	14,42 %	8,55 %	9,4 %
Current Ratio	0,99	1,33	1,79	1,54
Quick Ratio	1,23	1,68	1,79	1,54
Equity Ratio	0,13	0,18	0,53	0,6
Gross Profit Margin	100 %	100 %	100 %	100 %